Suchergebnisse - "Arthritis, Rheumatoid"

PubPharm (3)

1

Clinical review report : (Eli Lilly Canada Inc.)Baricitinib (Olumiant)

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, September 2019

CADTH common drug review

Version: final (with redactions).

2

Eficiency of different doses of rituximab in rheumatoid arthritis

enthalten in: Reumatologia clinica | 2016

von Mena-Vázquez, N. | Manrique-Arija, S. | Ureña-Garnica, I. | +5

3

Tocilizumab (Actemra) : adult patients with moderately to severely active rheumatoid arthritis

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, 2015

Common drug review

1
[1]